| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director, 10% Owner | Executive Chairman | Non-executive Chairman
3 companies
Gabriele M Cerrone is Director, 10% Owner at TLSA and has filed Form 4s across 3 companies. From April 2022 to July 2026, the filings on record show 14 open-market purchases and 0 sales. Gabriele M Cerrone's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $47.5M at current prices.
The biggest single holding is TLSA (~$30.9M) as Director, 10% Owner.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 19, 2022 | OKYO Okyo Pharma Ltd | Non-executive Chairman | Buy | 37,500 | $4.00 | $150,000.00 | +150.0% | -32.1% | -53.2% | |
| May 19, 2022 | OKYO Okyo Pharma Ltd | Executive Chairman | Buy | 5,800,000 | $0.08 | $440,800.00 | +1.1% | -32.1% | -53.2% | |
| May 17, 2022 | OKYO Okyo Pharma Ltd | Non-executive Chairman | Buy | 1,625,000 | $0.06 | $96,687.50 | +0.3% | -41.4% | -51.9% | |
| Apr 26, 2022 | ACUT Accustem Sciences Inc. | Director, 10% Owner | Buy | 9,447 | $1.43 | $13,490.69 | +0.2% | - | - |